The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change and Appointment of New Chairman

28 Jan 2020 16:53

RNS Number : 2100B
Maven Income and Growth VCT 5 PLC
28 January 2020
 

 

 

 

 

Maven Income and Growth VCT 5 PLC (the Company)

 

Directorate Change and Appointment of New Chairman

 

As announced in the Company's 2018 Annual Report and in the 2019 Interim Report, Allister Langlands will step down as Chairman and from the Board following the conclusion of the Company's Annual General Meeting (AGM) to be held on 28 April 2020.

 

Graham Miller was appointed to the Board as a Non-executive Director on 2 July 2019 and a resolution for Shareholders to confirm his election will be proposed at the 2020 AGM. Since his appointment, Mr Miller has proved to be a valuable member of the Board.

 

The Board, in considering a successor to Mr Langlands as Chairman, have agreed that Mr Miller is the most suitable candidate for the role. Accordingly, Mr Miller will assume the role of Chairman following the conclusion of the 2020 AGM.

 

Mr Miller began his business career with Murray Johnstone Private Equity in 1987, becoming a Director in 1994. He was Corporate Development Director of Avon Rubber PLC from 1998 to 2001 before returning to private equity with 3i plc. Since 2008, he has operated as an Independent Director and private investor.

 

Mr Miller currently chairs Westfield Medical Limited (a medical packaging MBO) and Shiner Limited (a family owned action sports distributor). He is a Non-executive Director of AIM listed Sutton Harbour Group PLC where he also chairs the Audit Committee and a Non-executive Director of Fidelius Financial Holdings Limited, a privately owned wealth management group.

 

The Board would like to thank Mr Langlands for his hard work and commitment to the role of Director and Chairman since his appointment on 1 June 2013 and wish him every success in his retirement.

 

 

Maven Capital Partners UK LLP

Company Secretary

 

28 January 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOADZGZMVRLGGZM
Date   Source Headline
25th Mar 20194:09 pmRNSStatement re Offer for Subscription
13th Mar 201912:12 pmRNSTransaction in Own Shares
7th Mar 20195:50 pmRNSIssue of Equity
4th Mar 201912:40 pmRNSNet Asset Value(s)
28th Feb 20195:42 pmRNSAnnual Financial Report
20th Feb 201912:30 pmRNSStatement re Offer for Subscription
15th Jan 20194:17 pmRNSTransaction in Own Shares
11th Jan 20193:50 pmRNSHolding(s) in Company
21st Dec 20181:00 pmRNSDirector/PDMR Shareholding
21st Dec 201810:39 amRNSIssue of Equity
18th Dec 20184:17 pmRNSNet Asset Value
5th Nov 20184:52 pmRNSTransaction in Own Shares
2nd Nov 201811:38 amRNSResult of General Meeting
10th Oct 20185:06 pmRNSTransaction in Own Shares
8th Oct 20184:48 pmRNSTransaction in Own Shares
5th Oct 20184:04 pmRNSTransaction in Own Shares
4th Oct 20183:03 pmRNSTransaction in Own Shares
3rd Oct 20187:00 amRNSNet Asset Value(s)
26th Sep 20186:29 pmRNSStatement re Offer for Subscription
24th Jul 20184:58 pmRNSTransaction in Own Shares
20th Jul 20182:56 pmRNSHalf-year Report
18th Jul 20189:21 amRNSNet Asset Value(s)
18th Jul 20187:00 amRNSStatement re Offer for Subscription
2nd May 20184:59 pmRNSHolding(s) in Company
25th Apr 20184:39 pmRNSNet Asset Value(s)
24th Apr 20181:34 pmRNSResult of AGM
12th Mar 20187:15 amRNSHolding(s) in Company
12th Mar 20187:00 amRNSAnnual Financial Report
8th Mar 20183:30 pmRNSDividend Declaration
27th Feb 20184:02 pmRNSTransaction in Own Shares
13th Feb 20183:39 pmRNSTransaction in Own Shares
25th Jan 20185:01 pmRNSTransaction in Own Shares
23rd Jan 20185:23 pmRNSTransaction in Own Shares
17th Jan 20182:46 pmRNSNet Asset Value(s)
3rd Jan 20182:00 pmRNSForm 8.3 - Plant Impact PLC
30th Nov 20174:42 pmRNSTransaction in Own Shares
29th Nov 20174:40 pmRNSTransaction in Own Shares
25th Oct 20173:05 pmRNSDividend Declaration
29th Sep 20174:01 pmRNSNet Asset Value(s)
23rd Aug 20174:50 pmRNSTransaction in Own Shares
23rd Aug 20177:00 amRNSTransaction in Own Shares
22nd Aug 20177:00 amRNSHalf-year Report
10th Aug 20174:11 pmRNSNet Asset Value and Interim Dividend
31st May 20174:58 pmRNSTransaction in Own Shares
16th May 20173:57 pmRNSTransaction in Own Shares
11th May 20172:03 pmRNSTransaction in Own Shares
25th Apr 20172:14 pmRNSResult of AGM
25th Apr 20172:12 pmRNSNet Asset Value and Proposed Final Dividend
6th Mar 20176:12 pmRNSAnnual Financial Report
6th Mar 20176:04 pmRNSCorrective Statement re Proposed Final Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.